Scleroderma renal crisis as an initial presentation of systemic sclerosis: a case report and review of the literature

Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S171-4. Epub 2015 Mar 6.

Abstract

Scleroderma renal crisis (SRC) is a life-threatening complication of systemic sclerosis (SSc) that is characterised by new-onset malignant hypertension and progressive acute renal failure, often with associated microangiopathic haemolytic anaemia and thrombocytopenia. SRC was at one time almost uniformly fatal, with death often occurring within a few weeks. With the development of angiotensin-converting-enzyme inhibitors (ACE-I), survival has improved dramatically, but death rates still remain unacceptably high. About 20% of SRC cases occur prior to making a diagnosis of SSc and, in some cases, there is no evidence of skin sclerosis at the time that SRC develops. In this report, we present a case in which a patient developed SRC prior to being diagnosed with scleroderma. Additionally, we review the pathogenesis, presenting signs and symptoms, management and prognosis of SRC.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Acute Kidney Injury / diagnosis
  • Acute Kidney Injury / drug therapy
  • Acute Kidney Injury / etiology*
  • Acute Kidney Injury / physiopathology
  • Anemia, Hemolytic / diagnosis
  • Anemia, Hemolytic / etiology
  • Angiotensin II Type 1 Receptor Blockers / therapeutic use
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Antihypertensive Agents / therapeutic use
  • Captopril / therapeutic use
  • Delayed Diagnosis
  • Drug Therapy, Combination
  • Female
  • Humans
  • Hypertension, Malignant / diagnosis
  • Hypertension, Malignant / drug therapy
  • Hypertension, Malignant / etiology*
  • Hypertension, Malignant / physiopathology
  • Middle Aged
  • Predictive Value of Tests
  • Renal Dialysis
  • Scleroderma, Systemic / complications*
  • Scleroderma, Systemic / diagnosis
  • Scleroderma, Systemic / drug therapy
  • Tetrazoles / therapeutic use
  • Thrombocytopenia / diagnosis
  • Thrombocytopenia / etiology
  • Time Factors
  • Treatment Outcome
  • Valine / analogs & derivatives
  • Valine / therapeutic use
  • Valsartan

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Angiotensin-Converting Enzyme Inhibitors
  • Antihypertensive Agents
  • Tetrazoles
  • Valsartan
  • Captopril
  • Valine